Circulation Research, Vol 72, 7-19, Copyright © 1993 by American Heart Association
ARTICLES |
GL Engelmann, CA Dionne and MC Jaye
Department of Medicine and Cell Biology, Loyola University Chicago, Stritch School of Medicine, Maywood, Ill. 60153.
Proliferative growth of the ventricular myocyte (cardiomyocyte) is primarily limited to fetal and early neonatal periods of development. In concert with the neonatal "transition" from proliferative to hypertrophic growth, ventricular remodeling of the nonmyocyte compartment is characterized by increased extracellular matrix synthesis/deposition and capillary angiogenesis. A role for locally generated and bioactive ventricular acidic fibroblast growth factor (aFGF) in these processes is proposed and substantiated by the following: 1) colocalization of aFGF peptide and fibroblast growth factor receptor (flg) transcripts to the developing fetal cardiomyocyte by immunohistochemistry, immunoelectron microscopy, and in situ hybridization, 2) continued localization of aFGF peptide and transcripts to the neonatal/mature cardiomyocyte, and 3) localization of flg immunoreactivity and transcripts to specific neonatal ventricular nonmuscle cell types. Specific ventricular cell types at distinct developmental stages appear to be responsive to ventricular myocyte-derived aFGF (myocytes in the fetal heart and nonmyocytes/endothelial cells in the neonatal heart). These data indicate that expression of aFGF and one of its receptors (flg) are most pronounced in the fetal to early neonatal ventricle, the presence of both suggesting an autocrine/paracrine growth regulatory function. As the animal matures, ventricular capillary angiogenesis may be facilitated by "release" of cardiomyocyte-derived fibroblast growth factors into the surrounding extracellular space/matrix functioning as a "paracrine" angiogenic stimuli. Therefore, the results of our study suggest that myocyte-derived aFGF may function to increase the fetal ventricular cardiomyocyte population in absolute number as well as to facilitate the subsequent increase in capillary angiogenesis that occurs during cardiomyocyte maturation and ventricular remodeling.
This article has been cited by other articles:
![]() |
C. K. Sen, S. Khanna, and S. Roy Perceived hyperoxia: Oxygen-induced remodeling of the reoxygenated heart Cardiovasc Res, July 15, 2006; 71(2): 280 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Palmen, M. J.A.P. Daemen, L. J. De Windt, J. Willems, W. R.M. Dassen, S. Heeneman, R. Zimmermann, M. Van Bilsen, and P. A. Doevendans Fibroblast growth factor-1 improves cardiac functional recovery and enhances cell survival after ischemia and reperfusion: A fibroblast growth factor receptor, protein kinase c, and tyrosine kinase-dependent mechanism J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1113 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lako-Futo, I. Szokodi, B. Sarman, G. Foldes, H. Tokola, M. Ilves, H. Leskinen, O. Vuolteenaho, R. Skoumal, R. deChatel, et al. Evidence for a Functional Role of Angiotensin II Type 2 Receptor in the Cardiac Hypertrophic Process In Vivo in the Rat Heart Circulation, November 11, 2003; 108(19): 2414 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.C Felmeden, A.D Blann, and G.Y.H Lip Angiogenesis: basic pathophysiology and implications for disease Eur. Heart J., April 1, 2003; 24(7): 586 - 603. [Full Text] [PDF] |
||||
![]() |
B. H. Alsan and T. M. Schultheiss Regulation of avian cardiogenesis by Fgf8 signaling Development, March 6, 2003; 129(8): 1935 - 1943. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Detillieux, F. Sheikh, E. Kardami, and P. A. Cattini Biological activities of fibroblast growth factor-2 in the adult myocardium Cardiovasc Res, January 1, 2003; 57(1): 8 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Tabibiazar and S.G Rockson Angiogenesis and the ischaemic heart Eur. Heart J., June 1, 2001; 22(11): 903 - 918. [PDF] |
||||
![]() |
L. K. Hornberger, S. Singhroy, T. Cavalle-Garrido, W. Tsang, F. Keeley, and M. Rabinovitch Synthesis of Extracellular Matrix and Adhesion Through {beta}1 Integrins Are Critical for Fetal Ventricular Myocyte Proliferation Circ. Res., September 15, 2000; 87(6): 508 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fernandez, A. Buehler, S. Wolfram, S. Kostin, G. Espanion, W. M. Franz, H. Niemann, P. A. Doevendans, W. Schaper, and R. Zimmermann Transgenic Myocardial Overexpression of Fibroblast Growth Factor-1 Increases Coronary Artery Density and Branching Circ. Res., August 4, 2000; 87(3): 207 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Reifers, E. Walsh, S Leger, D. Stainier, and M Brand Induction and differentiation of the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar) Development, January 1, 2000; 127(2): 225 - 235. [Abstract] [PDF] |
||||
![]() |
F. Sheikh, R. R. Fandrich, E. Kardami, and P. A. Cattini Overexpression of long or short FGFR-1 results in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures Cardiovasc Res, June 1, 1999; 42(3): 696 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lopez, E. R. Edelman, A. Stamler, M. G. Hibberd, P. Prasad, K. A. Thomas, J. Disalvo, R. P. Caputo, J. P. Carrozza, P. S. Douglas, et al. Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H930 - H936. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Fischer, P. L. McNeil, R. Khakee, P. Finn, R. A. Kelly, M. A. Pfeffer, and J. M. Pfeffer Cardiac Myocyte Membrane Wounding in the Abruptly Pressure-Overloaded Rat Heart Under High Wall Stress Hypertension, November 1, 1997; 30(5): 1041 - 1046. [Abstract] [Full Text] |
||||
![]() |
J. J. Lopez, E. R. Edelman, A. Stamler, M. G. Hibberd, P. Prasad, R. P. Caputo, J. P. Carrozza, P. S. Douglas, F. W. Sellke, and M. Simons Basic Fibroblast Growth Factor in a Porcine Model of Chronic Myocardial Ischemia: A Comparison of Angiographic, Echocardiographic and Coronary Flow Parameters J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 385 - 390. [Abstract] [Full Text] |
||||
![]() |
W. Schaper and W. D. Ito Molecular Mechanisms of Coronary Collateral Vessel Growth Circ. Res., November 1, 1996; 79(5): 911 - 919. [Full Text] |
||||
![]() |
M. C.G. Horrigan, A. I. MacIsaac, F. A. Nicolini, D. G. Vince, P. Lee, S. G. Ellis, and E. J. Topol Reduction in Myocardial Infarct Size by Basic Fibroblast Growth Factor After Temporary Coronary Occlusion in a Canine Model Circulation, October 15, 1996; 94(8): 1927 - 1933. [Abstract] [Full Text] |
||||
![]() |
K. B.S. Pasumarthi, E. Kardami, and P. A. Cattini High and Low Molecular Weight Fibroblast Growth Factor-2 Increase Proliferation of Neonatal Rat Cardiac Myocytes but Have Differential Effects on Binucleation and Nuclear Morphology : Evidence for Both Paracrine and Intracrine Actions of Fibroblast GrowthFactor-2 Circ. Res., January 1, 1996; 78(1): 126 - 136. [Abstract] [Full Text] |
||||
![]() |
Z.-S. Jiang, R. R. Padua, H. Ju, B. W. Doble, Y. Jin, J. Hao, P. A. Cattini, I. M. C. Dixon, and E. Kardami Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1071 - H1080. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |